European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

MT Newswires Live12-05

European equities traded in the US as American depositary receipts were slightly higher late Wednesday morning, rising 0.15% to 1,345.27 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by software firm SAP (SAP) and furniture maker Natuzzi (NTZ), which increased 4.3% and 2.9%, respectively. They were followed by biopharmaceutical company argenx (ARGX) and internet advertising firm Criteo (CRTO), which were up 1.9% and 1.7%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and accommodations booking company trivago (TRVG), which dropped 5.8% and 4.7%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biotech firm Evaxion Biotech (EVAX), which were down 2.7% and 2.4%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and pharmaceutical company Silence Therapeutics (SLN), which advanced 10% and 2.2%, respectively. They were followed by software firm Endava (DAVA) and cruise line operator Carnival (CUK), which rose 2% and 1.9%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which fell 6.5% and 4.6%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which lost 3% and 2.9%, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment